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Purpose: Chronic obstructive pulmonary disease (COPD) is characterized by 
chronic inflammation of the airways and progressive destruction of lung paren-
chyma. Apoptosis is critical for the maintenance of normal tissue homeostasis 
and is in equilibrium with proliferation and differentiation. This study was under-
taken to investigate relationship between apoptosis of peripheral blood lympho-
cytes during exacerbation of COPD and inflammatory response that characterizes 
this condition. Materials and Methods: Seventeen patients with COPD exacer-
bation, 21 stable COPD, and 12 control subjects were included. T lymphocytes 
were isolated from peripheral blood using MACS. Apoptosis of T lymphocytes 
was assessed with FACS using annexin V and 7-aminoactinomycin. Serum levels 
of interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF)-α were determined by 
an immunoassay technique. Results: There was significantly increased percent-
age of apoptotic lymphocytes, CD 4+, and CD 8+ T cells in the peripheral blood of 
patients with exacerbation of COPD compared with stable COPD. Serum levels 
of IL-6, IL-8, and TNF-α were significantly increased in patients with exacerba-
tion of COPD compared with stable COPD. Only TNF-α presented a positive 
correlation with apoptotic lymphocytes in patients with exacerbation of COPD. 
Conclusion: Increased apoptotic lymphocytes may be associated with upregula-
tion of TNF-α in the peripheral blood of patients with acute exacerbation of 
COPD.
Key Words:    Chronic obstructive pulmonary disease, apoptosis, lymphocyte, tu-
mor necrosis factor-α
INTRODUCTION
   
Chronic obstructive pulmonary disease (COPD) is characterized by an abnormal 
inflammatory response to respiratory pollutants, mostly from tobacco smoking. 
This inflammation in the repair process can alter respiratory structure and func-
tion.1,2 In the control of repair process, apoptosis is an important mechanism that Sung Chul Lim, et al.
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MATERIALS AND METHODS
　　　
Study subjects
A total of 50 subjects were enrolled in the study from Janu-
ary 2008 to March 2009. COPD was diagnosed on the basis 
of the Global Initiative for Chronic Obstructive Lung Dis-
ease criteria.17 The inclusion criteria were a smoking history 
of at least 20 pack-years, a postbronchodilator forced expira-
tory volume one-second (FEV1)/forced vital capacity (FVC) 
ratio <70%, and an FEV1 <80% of the predicted values. Ex-
clusion criteria were respiratory disorders other than COPD, 
pulmonary embolism, infectious diseases, malignancy, left 
ventricular dysfunction, recent surgery, and severe endocrine, 
hepatic, or renal diseases. The exacerbation of COPD was 
defined by any combination of the following major criteria: 
aggravation of dyspnea, increase in sputum volume, and in-
crease in sputum purulence; other minor criteria (upper respi-
ratory tract infection in the last 5 days, fever, increased 
wheezing, increased cough) were also considered.18 All mea-
surements were performed in patients with exacerbation of 
COPD during the first 24 hours of hospital admission. Stable 
COPD patients without a history of exacerbation for the pre-
vious 2 months were recruited from our outpatient settings. 
The control group consisted of current or former smokers 
with normal lung function. The inclusion criteria of control 
group were as follows: 1) older than 50 years of age in or-
der to match the COPD group, 2) smoking history of at 
least 20 pack-years, 3) FEV1/FVC ratio >70%, FEV1 >80% 
of the predicted value, and 4) no other pulmonary disease 
by history and chest radiography. 
This study protocol was approved by Chonnam National 
University Hospital Ethics Committee (CRI08058-1), and 
all subjects provided informed written consent before par-
ticipation. 
Isolation and culture of lymphocytes
Peripheral blood mononuclear cells (PBMC) were isolated 
by density gradient centrifugation on Lymphoprep (Axis-
Shield; Oslo, Norway) from 50-60 mL of heparinized blood. 
PBMCs were suspended in RPMl 1,640 culture medium 
with 10% fetal bovine serum supplemented with 0.2 L gluta-
mine, 25 U/mL penicillin and 25 mg/mL streptomycin. T 
cells were, thereafter, separated in aliquots and cultured in 
sterile polypropylene tubes (Greiner; Frickenhausen, Germa-
ny) at 37°C and 5% CO2 for 24 hours. The CD4+ and CD8+ 
T cells were enriched by magnetically activated cell sorting 
is related to the regulation of normal cell turnover in lungs. 
Increasing evidence indicates that disturbance of the bal-
ance between apoptosis and proliferation of lung tissue 
contributes to the pathogenesis of COPD.3-7 T lymphocytes 
play a central role in orchestrating cellular and humoral 
immune responses to agents such as bacteria, viruses and 
allergens. Activated T cells are increased in the airways in 
COPD and they could affect the development of the dis-
ease.3 Apoptosis should remove these activated T cells at 
the end of an inflammatory response to maintain cellular 
homeostasis.4,8 Apoptosis can be initiated through two ma-
jor pathways, one is a death receptor ligation and the other 
the release of cytochrome C from mitochondria.8 The 
death receptor pathway is triggered by the ligation of the 
tumor necrosis factor (TNF) family, such as TNF-α and 
Fas-ligand, to their respective ligands, TNF receptor 1, and 
Fas. These “death-inducing” receptors can be making an 
interaction with adaptor proteins such as Fas associated 
death domain protein (FADD). FADD affects caspase-8 
activation which leads to either direct activation of cas-
pase-3, or to cleavage of Bid, a member of the bcl-2 fami-
ly, that targets mitochondria for cytochrome c release.9,10 
Majo, et al.5 demonstrated increased apoptosis of lympho-
cytes obtained from the airways by bronchoalveolar lavage 
of patients with COPD, and Segura-Valdez, et al.6 de-
scribed an increase in endothelial cell apoptosis in lung tis-
sue sections from COPD patients. 
Acute exacerbations of COPD can contribute to continu-
ous tissue damage and progressive bronchial obstruc-
tion.11,12 Several cytokines such as interleukin (IL)-6, IL-8 
and TNF-a which are involved in the local and systemic 
inflammation during exacerbation are also associated with 
the regulation of apoptosis.13-15 Schmidt-Ioanas, et al.16 re-
ported a significant decrease of the apoptotic neutrophils 
during COPD exacerbation. However, little evidence ex-
ists concerning the regulation of the circulating lympho-
cytes apoptosis in patients with exacerbation of COPD. 
Based on these findings, it is highly possible that the pat-
tern of apoptosis of the peripheral blood lymphocytes is re-
lated to the increased immune response in patients with ex-
acerbation of COPD. Cytokines involved in the local and 
systemic inflammation during exacerbation are also associ-
ated with the regulation of apoptosis. The aim of the cur-
rent study was to investigate T lymphocytes apoptosis in 
peripheral blood from patients with exacerbation of COPD 
in order to investigate the relationship between lympho-
cytes apoptosis and cytokines.Lymphocytes Apoptosis in COPD Exacerbation
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Inc; Chicago, IL, USA) was used for all statistical analyses. 
The data are presented as mean±SD for variables that were 
normally distributed, whereas they are expressed as the me-
dian and interquartile range (IQR) for variables that were 
not normally distributed. Multiple comparisons were per-
formed by one-way analysis of variance (ANOVA). When 
ANOVA revealed a significant difference, the Bonferroni 
correction was applied. The correlation between apoptotic 
lymphocytes and cytokine levels were evaluated by Spear-
man’s coefficient. A p value of <0.05 was considered statis-
tically significant.
   
RESULTS
 
Clinical characteristics
Table 1 presents the clinical and lung function variables of all 
participants. We included 17 patients with exacerbation of 
COPD, 21 patients with clinically stable COPD, and 12 con-
trol groups in the study. Most subjects included in this study 
were male. The three groups of subjects were similar with re-
gard to age, gender and smoking history. By design, the re-
sults of pulmonary function test were normal in control 
groups. FEV1 was significantly decreased in patients with ex-
acerbation of COPD compared to the stable COPD patients. 
CD4+ and CD8+ T cells in peripheral blood  
The percentage of CD8+ T cells was significantly increased 
in the peripheral blood of patients with exacerbation of 
COPD compared to stable COPD and control groups (exac-
erbation COPD 30.8±11.7; stable COPD 21.1±9.5; control 
group 16.8±8.7, p=0.02), and there were significant differ-
(MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). 
Usually, MACS did not alter structure, function, or activity 
status of labeled cells and did not influence flow cytometry.
Assessment of T lymphocytes apoptosis
To determine the apoptosis, we used flow cytometry (FACS 
Calibur; Becton Dickinson, UK) with double labeling with 
annexin V (Becton Dickinson; Plymouth, UK) and 7-amino-
actinomycin (7 AAD) (Becton Dickinson; Plymouth, UK). 
Briefly, the isolated lymphocytes were washed and centri-
fuged in binding buffer [0.1 M HEPES/NaOH (pH 7.4), 
1.4M NaCl, 25mM CaCl2] and the pellet was resuspended in 
5 mL of annexin V, 5 mL of 7AAD and 100 mL of binding 
buffer, followed by incubation for 15 minutes at room tem-
perature in dark. Measurement was performed by flow cy-
tometry within 15 minutes. We collected 20,000 cells in each 
sample using CellQuest software (Becton Dickinson; Moun-
tain View, CA, USA), and results were expressed as a per-
centage of cells exhibiting positive fluorescence.
Measurement of serum IL-6, IL-8 and TNF-α level
For the measurement of IL-6, IL-8 and TNF-α, blood was 
collected in plastic tubes containing EDTA (Becton Dickin-
son; Plymouth, UK) and was centrifuged within an hour 
(1,000×g for 10 min). The supernatants were stored at -70°C 
until analysis. Cytokines were measured by a commercially 
available sandwich enzyme-linked immunoassay (R&D 
systems; Minneapolis, MN, USA). The results were given 
as pg/mL.
Statistical analysis
A statistical software package (SPSS, version 17.0; SPSS 
Table 1. Demographic Characteristics of the Subjects
Control group
COPD
Stable Acute exacerbation
Gender
    Male, no (%) 11 (91.7) 20 (95.2) 13 (76.5)
    Female, no (%) 1 (8.3) 1 (4.8)   4 (23.5)
Age, yrs  62.5±7.9 64.9±7.1 68.3±7.7
Smoking status
   Current smoker, no (%)   7 (58.3) 11 (52.4)   9 (52.9)
   Smoking, pack-yr   33.3±17.2   36.1±19.2   35.2±23.7
FEV1, % predicted 103.0±11.5      56.9±15.6 *      36.7±14.5*
†
FEV1/FVC ratio, % 88.1±5.1      45.2±12.6 *      42.1±11.7 *
Values are expressed as mean±SD. 
FEV1, forced expiratory volume in one second; FVC, forced vital capacity.
*p<0.05 compared with control groups.
†p<0.05 compared with stable COPD.Sung Chul Lim, et al.
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p=0.015). Apoptosis of CD4+ T cells was significantly in-
creased in patients with exacerbation of COPD compared 
with stable COPD (18.6±4.4% vs. 14.9±4.5%; p=0.015). 
Also, apoptosis of CD8+ T cells was significantly increased 
in patients with exacerbation of COPD compared with sta-
ble COPD (18.3±3.7% vs. 14.5±5.4%; p=0.030).
Serum levels of cytokines
Serum levels of IL-6 were significantly increased in patients 
with exacerbation of COPD compared with the stable 
COPD and control groups [median, IQR, expressed in pg/
mL: exacerbation COPD 19.67 (13.55-23.25); stable COPD 
6.58 (3.19-9.54); control group 2.86 (2.35-4.62), ANOVA 
p<0.001] (Fig. 2A). Serum IL-8 levels were significantly 
higher in patients with exacerbation of COPD than in the 
stable COPD and control groups [median, IQR, expressed in 
pg/ml: exacerbation COPD 87.87 (70.31-91.51); stable 
COPD 30.38 (27.46-39.83); control group 27.36 (26.08-
32.20), ANOVA p<0.001] (Fig. 2B). However, no differenc-
es were observed in IL-6 and IL-8 levels between the stable 
COPD and control groups. Serum levels of TNF-α were sig-
ences between the stable COPD and control groups. The per-
centage of blood CD4+ T cells decreased in patients with ex-
acerbation of COPD compared to stable COPD and control 
groups (exacerbation COPD 69.1±14.5; stable COPD 
78.8±10.2; control group 83.1±15.8, p=0.03), although there 
was no significant difference between the stable COPD and 
control groups. The ratio of CD4+/CD8+ T cells was signifi-
cantly decreased in patients with exacerbation of COPD 
compared to stable COPD and control groups (exacerbation 
COPD 2.0±1.6; stable COPD 3.4±1.7; control group 4.7±3.9, 
p=0.01), and there was significant difference between the sta-
ble COPD and control groups.
Quantitation of apoptosis by flow cytometry 
Fig. 1 shows the percentage of T lymphocytes, CD 4+ and 
CD 8+ T cells in the three groups studied. There was signifi-
cantly increased apoptosis of T lymphocytes, CD4+ and 
CD8+ T cells in COPD patients (stable or exacerbated 
COPD) compared with control groups. Apoptosis of lym-
phocytes was significantly higher in patients with exacerba-
tion of COPD than stable COPD (19.8±3.1% vs. 16.1±4.7%; 
Fig. 1. Mean apoptosis percentage of peripheral blood T lymphocytes (A), CD 4
+ T cells (B), and CD 8
+ T cells (C) in control groups, stable COPD, and exacer-
bation of COPD measured by flow cytometry. COPD, chronic obstructive pulmonary disease.
Fig. 2. The serum levels of IL-6 (A), IL-8 (B), and TNF-α (C) in control groups, stable COPD, and exacerbation of COPD. Serum cytokine levels are expressed 
as the median value and interquartile range. •, outlier extending >1.5 box-lengths from the edge of the box. IL-6, interleukin-6; IL-8, interleukin-8; TNF-α, tumor 
necrosis factor-alpha. COPD, chronic obstructive pulmonary disease.
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apoptotic stimuli in the airways or from apoptotic stimuli in 
the peripheral blood. Secondary necrosis may result in-
creased apoptotic T-cells in the lung that has a pro-inflam-
matory effect. Furthermore, defective immune response to 
infective organisms can be caused by increased T-cell apop-
tosis, which contributes to the high frequency of infections 
seen in COPD.20 However, increased apoptosis of peripher-
al blood T lymphocytes does not explain clearly its causal 
relationship with the pathogenesis of COPD. Hodge, et al.20 
demonstrated increased propensity of peripheral blood T 
cells in COPD to undergo apoptosis. Recent study shows 
87% increase in the apoptosis of airway epithelial cells and 
103% increase of T lymphocytes apoptosis in bronchial 
brushings and bronchoalveolar lavage in COPD patients 
compared to non-smoking controls.21 On the contrary, how-
ever, others did not find a significant difference in apoptotic 
alveolar wall cells in the lungs from smokers without em-
physema compared to smokers with emphysema.5 In the 
present study, we found increased apoptosis of T lympho-
cytes from peripheral blood in COPD patients compared to 
control groups.
The frequent occurrence of exacerbations is an important 
feature of COPD. There is enhancement of both local air-
way and systemic inflammation during exacerbations. Spu-
tum, serum, urine and exhaled air samples have been ana-
lyzed during acute exacerbations.22-27 In our study, serum 
levels of IL-6, IL-8 and TNF-α were significantly higher in 
patients with exacerbation of COPD compared to stable 
COPD patients. Apoptosis can be regulated by several cy-
tokines which are involved in the local and systemic in-
flammation during exacerbation.11-15 The report from Duni-
can, et al.14 suggested that TNF-α stimulates neutrophils 
apoptosis, while prolonged exposure has an inhibitory ef-
nificantly increased in patients with exacerbation of COPD 
compared with stable COPD and control groups. Also in-
creased levels of TNF-α were observed in stable COPD pa-
tients compared with control groups [median, IQR, ex-
pressed in pg/mL: exacerbation COPD 139.33 (105.98-
175.17); stable COPD 57.31 (29.38-109.03); control group 
26.05 (21.67-29.07), ANOVA p<0.001] (Fig. 2C).
   
Correlation of apoptotic lymphocytes with serum 
cytokines 
Only TNF-α presented a positive correlation with apoptotic 
lymphocytes in patients with stable COPD (r=0.470, p= 
0.032) and exacerbation of COPD (r=0.613, p=0.009). Se-
rum levels of IL-6 and IL-8 were not correlated with apop-
totic lymphocytes in patients with stable and exacerbation 
of COPD (Table 2).
DISCUSSION
   
The pathophysiology of COPD includes inflammation, im-
balance of protease and anti-protease, oxidative stress, and 
apoptosis. Abnormal apoptotic events have been demon-
strated in epithelial and endothelial cells as well as in in-
flammatory cells including neutrophils and lymphocytes in 
lungs with COPD patients. The main finding of our present 
study was that, compared to stable COPD, circulating apop-
totic lymphocytes, CD 4+ and CD 8+ T cells were significant-
ly increased in patients with exacerbation of COPD. TNF-α 
presented a positive correlation with apoptotic lymphocytes 
in patients with exacerbation of COPD. 
COPD is currently regarded as a multi-component dis-
ease with systemic manifestations in addition to local pul-
monary inflammation. This inflammation leads to recurring 
cycles of injury and repair, and disorders in the repair pro-
cess can lead to tissue remodeling with altered structure and 
function.1,2 Apoptotic cells are rarely seen in the normal hu-
man lung,19 suggesting either low rates of cell death or a 
rapid removal process. This are increasing evidences to in-
dicate that disturbance of the balance between apoptosis 
and proliferation in lung tissue contributes to the pathogen-
esis of COPD.3-7 The increased numbers of T-cells may de-
rived from local proliferation of T-cells in the lung of COPD 
or enhanced trafficking from the bloodstream. This process 
develops also from the airways to the bloodstream. There-
fore, it is possible that increased apoptosis of T-cells in the 
peripheral blood in COPD may result either from local 
Table 2. Correlation between the Percentage of Apoptotic 
Lymphocytes and Serum Levels of IL-6, IL-8, and TNF-α in 
Patients with Stable and Exacerbation of COPD
Cytokine r p value
Stable COPD
    IL-6 0.101 0.662
    IL-8 0.091 0.695
    TNF-α 0.470 0.032
Exacerbation of COPD
    IL-6 0.201 0.939
    IL-8 0.010 0.970
    TNF-α 0.613 0.009
IL-6, interleukin-6; IL-8, interleukin-8; TNF-α, tumor necrosis factor-alpha; 
r, Spearman’s correlation coefficient; COPD, chronic obstructive pulmonary 
disease.Sung Chul Lim, et al.
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fect mediated by the anti-apoptotic chemokine IL-8. A 
study of Biffl, et al.15 showed that IL-6 can also delay neu-
trophil apoptosis. The uptake of apoptotic neutrophils may 
not only suppress the release of proinflammatory agents, 
such as IL-1β, IL-8, and TNF, but also increase macro-
phage release of agents, such as transforming growth factor 
β, and prostaglandin E2, that have suppressive influences 
on the inflammatory response.28,29 A recent study revealed a 
significant reduction of percentage of apoptotic neutrophils 
at the development of COPD exacerbation. Apoptotic neu-
trophils are not related to serum and sputum levels of IL-6, 
IL-8 and TNF-α.16 However, to our best knowledge, little ev-
idence exists concerning the regulation of the circulating 
lymphocytes apoptosis in patients with exacerbation of 
COPD. Our present study revealed a significantly increased 
percentage of apoptotic circulating lymphocytes in patients 
with exacerbation of COPD compared to stable COPD pa-
tients. Only TNF-α presented a positive correlation with apop-
totic lymphocytes in patients with exacerbation of COPD. 
In summary, this study demonstrated an increased per-
centage of apoptotic lymphocytes, CD 4+, and CD 8+ T cells 
from the peripheral blood in patients with exacerbation of 
COPD compared with stable COPD. Serum levels of IL-6, 
IL-8, and TNF-α were significantly increased in patients 
with exacerbation of COPD compared with stable COPD. 
Only TNF-α showed a positive correlation with apoptotic 
lymphocytes in patients with exacerbation of COPD. Based 
on these findings, we postulate that increased apoptotic lym-
phocytes may be associated with upregulation of TNF-α in 
the peripheral blood of patients with acute exacerbation of 
COPD. 
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